Search Results (844)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro. | Academic Article |
Why?
|
| State of immunosuppressive agents in organ transplantation. | Academic Article |
Why?
|
| Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail. | Academic Article |
Why?
|
| The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. | Academic Article |
Why?
|
| Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response. | Academic Article |
Why?
|
| Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow? | Academic Article |
Why?
|
| "Hit me with your best shot... Fire away!". | Academic Article |
Why?
|
| "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. | Academic Article |
Why?
|
| A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. | Academic Article |
Why?
|
| A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. | Academic Article |
Why?
|
| A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. | Academic Article |
Why?
|
| A diagnosis that eats at you. | Academic Article |
Why?
|
| A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. | Academic Article |
Why?
|
| A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. | Academic Article |
Why?
|
| A phase I multiple-dose escalation study characterizing pharmacokinetics and safety of ABT-578 in healthy subjects. | Academic Article |
Why?
|